Trials / Conditions / Postmenopausal Vaginal Atrophy

Postmenopausal Vaginal Atrophy

8 registered clinical trials studyying Postmenopausal Vaginal Atrophy.

Status	Trial	Sponsor	Phase
Completed	Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal At NCT05243823	Novo Nordisk A/S	—
Completed	Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginiti NCT01085877	Novo Nordisk A/S	Phase 1
Completed	Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis NCT00431132	Novo Nordisk A/S	Phase 3
Completed	Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis NCT01486979	Novo Nordisk A/S	Phase 1
Completed	Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency NCT01507454	Novo Nordisk A/S	—
Completed	Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms NCT00108849	Novo Nordisk A/S	Phase 3
Completed	Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial NCT00464971	Novo Nordisk A/S	Phase 3
Completed	Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis NCT00465192	Novo Nordisk A/S	Phase 3